Development of a predictor for human brain tumors based on gene expression values obtained from two types of microarray technologies

OMICS A Journal of Integrative Biology

Volumn 14, Issue 2, 2010, Pages 157-164

  Castells, Xavier ^a,e   Acebes, Juan José ^b,e   Boluda, Susana ^b   Moreno Torres, Àngel ^c,e   Pujol, Jesús ^d,e   Julià Sapé, Margarida ^e   Candiota, Ana Paula ^e   Ariño, Joaquín ^a   Barceló, Anna ^a   Arús, Carles ^a,e  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c Centre Diagnòstic Pedralbes   (Spain)

^d Institut d'Alta Tecnologia   (Spain)

^e BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; COMPLEMENTARY DNA; GLYCOPROTEIN M6B; GREEN FLUORESCENT PROTEIN; PROLINE ARGININE RICH END LEUCINE RICH REPEAT PROTEIN; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE ZETA 1; SECRETED FRIZZLED RELATED PROTEIN 2; SOLUTE CARRIER FAMILY 6 MEMBER 2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BRAIN BIOPSY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MARKER GENE; MENINGIOMA; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

BRAIN NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 77950812699     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2009.0093     Document Type: Article

References (24)

1. Baba, H., Nakahira, K., Morita, N., Tanaka, F., Akita, H., and Ikenaka, K. (1997). GFAP gene expression during development of astrocyte. Dev Neurosci 19, 49-57. (Pubitemid 27095954)
2. Borozan, I., Chen, L., Paeper, B., Heathcote, J.E., Edwards, A.M., Katze, M., et al. (2008). MAID: an effect size based model for microarray data integration across laboratories and platforms. BMC Bioinformatics 9, 305.
3. Bosotti, R., Locatelli, G., Healy, S., Scacheri, E., Sartori, L., Mercurio, C., et al. (2007). Cross platform microarray analysis for robust identification of differentially expressed genes. BMC Bioinformatics 8(Suppl 1), S5. (Pubitemid 351863381)
4. Castells, X., García-Gómez, J.M., Navarro, A.T., Acebes, J.J., Godino, O., Boluda, S., et al. (2009). Automated brain tumor biopsy prediction using single-labeling cDNA microarrays-based gene expression profiling. Diag Mol Pathol 18, 206-278.
5. Dupuy, A., and Simon, R.M. (2007). Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 99, 147-157.
6. Edwards, D. (2003). Non-linear normalization and background correction in one-channel cDNA microarray studies. Bioinformatics 19, 825-833. (Pubitemid 36582398)
7. Eng, L.F., Ghirnikar, R.S., and Lee, Y.L. (20002). Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25, 1439-1451.
8. Hwang, K.B., Kong, S.W., Greenberg, S.A., and Park, P.J. (2004). Combining gene expression data from different generations of oligonucleotide arrays. BMC Bioinformatics 5, 159.
9. Khan, M.U., Choi, J.P., Shin, H., and Kim, M. (2008). Predicting breast cancer survivability using fuzzy decision trees for personalized healthcare. Proc Annu Int Conf IEEE Eng Med Biol Soc 5148-5151.
10. Kleihues, P., and Cavenee, W.K. (2000). Pathology and Genetics of Tumours of the Nervous System, 3rd ed. (IARC, Lyon).
11. Lee, Y., Scheck, A.C., Cloughesy, T.F., Lai, A., Dong, J., Farooqi, H.K., et al. (2008). Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age. BMC Med Genomics, 1-52.
12. Liu, H.C., Chen, C.Y., Liu, Y.T., Chu, C.B., Liang, D.C., Shih, L.Y., et al. (2008). Cross-generation and cross-laboratory predictions of Affymetrix microarrays by rank-based methods. J Biomed Informatics 41, 570-579.
13. Louis, D.N., Ohgaki, H., Wiestler, O.D., and Cavenee, W.K. (2007). WHO Classification of Tumours of the Central Nervous System, 4th ed. (IARC, Lyon).
14. Muller, S., Lamszus, K., Nikolich, K., and Westphal, M. (2004). Receptor protein tyrosine phosphatase zeta as a therapeutic target for glioblastoma therapy. Expert Opin Ther Targets 8, 211-220. (Pubitemid 38877672)
15. Nutt, C.L., Mani, D.R., Betensky, R.A., Tamayo, P., Cairncross, J.G., Ladd, C., et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63, 1062-1067.
16. Phillips, H.S., Kharbanda, S., Chen, R., Forrest, W.F., Soriano, R.H., Wu, T.D., et al. (2006). Molecular subclasses of highgrade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173. (Pubitemid 43357943)
17. Shi, L., Reid, L.H., Jones, W.D., Shippy, R., Warrington, J.A., Baker, S.C., et al. (2006). The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nature Biotechnol 24, 1151-1161. (Pubitemid 44359727)
18. Sotiriou, C., and Piccart, M.J. (2007). Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer 7, 545-553. (Pubitemid 46985399)
19. Storey, J.D., and Tibshinni, R. (2003). Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100, 9440-9445.
20. Sun, Z., and Yang, P. Gene expression profiling on lung cancer outcome prediction: present clinical value and future premise. (2006). Cancer Epidemiol Biomarkers Prev 15, 2063-2068.
21. Tate, A.R., Underwood, J., Acosta, D.M., Julià -Sapé, M., Majó s, C., Moreno-Torres, A. et al. (2006). Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed 19, 411-434. (Pubitemid 43997763)
22. Tonini, G.P., and Pistoia, V. (2006). Molecularly guided therapy of neuroblastoma: a review of different approaches. Curr Pharm Des 12, 2303-2317. (Pubitemid 43891401)
23. Wang, T.H., and Chao, A. (2007). Microarray analysis of gene expression of cancer to guide the use of chemotherapeutics. Taiwan J Obstet Gynecol 46, 222-229. (Pubitemid 47572281)
24. Yang, L., Tuzel, O., Chen, W., Meer, P., Salaru, G., Goodell, L., et al. (2009). PathMiner: a Web-based tool for computerassisted diagnostics in pathology and Foran D. IEEE Trans Inform Technol Biomed 13, 291-299.